BioMarin Pharmaceutical, Inc. (BMRN)
54.59
-0.48
(-0.87%)
USD |
NASDAQ |
Jan 16, 16:00
54.79
+0.20
(+0.37%)
After-Hours: 05:09
BioMarin Pharmaceutical EPS Diluted (Quarterly): -0.1601 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| Gilead Sciences, Inc. | 2.434 |
| Merck & Co., Inc. | 2.316 |
| AbbVie, Inc. | 0.0993 |
| Biogen, Inc. | 3.171 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.74M |
| Revenue (Quarterly) | 786.77M |
| Total Expenses (Quarterly) | 817.52M |
| Enterprise Value | 9.621B |
| Gross Profit Margin (Quarterly) | 81.58% |
| Profit Margin (Quarterly) | -3.91% |
| Earnings Yield | 4.89% |
| Operating Earnings Yield | 8.01% |
| Normalized Earnings Yield | 6.537 |